Show Article with tag "investors"

A Battle for Transparency: Inhlanhla Ventures and the JSE A small company, Inhlanhla Ventures, found itself in a precarious financial situation after investing in shares on the stock market. Through a broker, it received credit to invest, with shares held as security for those loans. However, when the value of these shares dropped significantly, the […]

BioCryst Pharmaceuticals (BCRX) is preparing to announce its financial results for the second quarter of 2025 on August 4th, prior to the market opening. Analysts predict revenues of approximately $148.85 million for the quarter. Earnings per share (EPS) are projected to be around 3 cents.We found this resource helpful: Japan grapples with its past 80 […]